P1517: HUMORAL AND CELLULAR IMMUNE RESPONSES TO SARS-COV-2 NATURAL INFECTION OR VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000972948.48342.7a |
| _version_ | 1827332454040469504 |
|---|---|
| author | Alessandro Campanella Antonella Capasso Caterina Taccetti Silvia Heltai Elisa Albi Yair Herishanu Sabine Haggenburg Thomas Chatzikonstantinou Michael Doubek Magdalena Kättström Krzysztof Giannopoulos Martin Simkovic Carol Moreno Massimo Massaia Horia Bumbea Salem Al Shimmari Pamela Ranghetti Eleonora Perotta Francesca Martini Emanuela Sant’antonio Maria Colia Catalina Combi Shai Levi Arnon Kater Mette Hazenberg Inger Nijhof Quincy Hofsink Christos Demosthenous Jana Kotaskova Joanna Zaleska Filip Vrbacky Alba Mora Davide Bisogno Ignazio Ezio Tripoli Viola Maria Popov Viviana Roman Eloise Scarano Michela Frenquelli Lydia Scarfò Kostas Stamatopoulos Paolo Ghia |
| author_facet | Alessandro Campanella Antonella Capasso Caterina Taccetti Silvia Heltai Elisa Albi Yair Herishanu Sabine Haggenburg Thomas Chatzikonstantinou Michael Doubek Magdalena Kättström Krzysztof Giannopoulos Martin Simkovic Carol Moreno Massimo Massaia Horia Bumbea Salem Al Shimmari Pamela Ranghetti Eleonora Perotta Francesca Martini Emanuela Sant’antonio Maria Colia Catalina Combi Shai Levi Arnon Kater Mette Hazenberg Inger Nijhof Quincy Hofsink Christos Demosthenous Jana Kotaskova Joanna Zaleska Filip Vrbacky Alba Mora Davide Bisogno Ignazio Ezio Tripoli Viola Maria Popov Viviana Roman Eloise Scarano Michela Frenquelli Lydia Scarfò Kostas Stamatopoulos Paolo Ghia |
| author_sort | Alessandro Campanella |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:01:08Z |
| format | Article |
| id | doaj.art-95dec98f89594135be22f30c2711ec0e |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T17:01:08Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-95dec98f89594135be22f30c2711ec0e2024-03-03T03:24:51ZengWileyHemaSphere2572-92412023-08-017e483427a10.1097/01.HS9.0000972948.48342.7a202308003-01411P1517: HUMORAL AND CELLULAR IMMUNE RESPONSES TO SARS-COV-2 NATURAL INFECTION OR VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLLAlessandro Campanella0Antonella Capasso1Caterina Taccetti2Silvia Heltai3Elisa Albi4Yair Herishanu5Sabine Haggenburg6Thomas Chatzikonstantinou7Michael Doubek8Magdalena Kättström9Krzysztof Giannopoulos10Martin Simkovic11Carol Moreno12Massimo Massaia13Horia Bumbea14Salem Al Shimmari15Pamela Ranghetti16Eleonora Perotta17Francesca Martini18Emanuela Sant’antonio19Maria Colia20Catalina Combi21Shai Levi22Arnon Kater23Mette Hazenberg24Inger Nijhof25Quincy Hofsink26Christos Demosthenous27Jana Kotaskova28Joanna Zaleska29Filip Vrbacky30Alba Mora31Davide Bisogno32Ignazio Ezio Tripoli33Viola Maria Popov34Viviana Roman35Eloise Scarano36Michela Frenquelli37Lydia Scarfò38Kostas Stamatopoulos39Paolo Ghia401 IRCCS Ospedale San Raffaele, Laboratory of B cell Neoplasia, Milano, Italy2 Università Vita Salute San Raffaele, Milano, Italy1 IRCCS Ospedale San Raffaele, Laboratory of B cell Neoplasia, Milano, Italy1 IRCCS Ospedale San Raffaele, Laboratory of B cell Neoplasia, Milano, Italy3 IRCCS Ospedale San Raffaele, Strategic Research Program on CLL, Milano, Italy4 Tel Aviv Sourasky Medical Center, Department of Hematology, Tel Aviv, Israel6 Amsterdam UMC, Department of Hematology, Amsterdam, The Netherlands7 Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece8 University Hospital Brno, Department of Internal Medicine-Hematology and Oncology, Brno, Czech Republic9 Örebro University, Section of Hematology, Department of Medicine, Faculty of Medicine and Health, Örebro, Sweden10 Medical University of Lublin, Department of Experimental Hematooncology, Lublin, Poland11 University Hospital and Charles University in Prague, 4th Department of Internal Medicine – Hematology, Faculty of Medicine in Hradec Králové, Prague, Czech Republic12 Hospital de la Santa Creu I Sant Pau, Josep Carreras Leukaemia Research Institute, Department of Hematology, Barcelona, Spain13 AO S.Croce e Carle, SC Ematologia, Cuneo, Italy15 Emergency University Clinical Hospital, Bucharest, Romania17 Kuwait University, Department of Medicine, Faculty of Medicine, Safat, Kuwait1 IRCCS Ospedale San Raffaele, Laboratory of B cell Neoplasia, Milano, Italy1 IRCCS Ospedale San Raffaele, Laboratory of B cell Neoplasia, Milano, Italy3 IRCCS Ospedale San Raffaele, Strategic Research Program on CLL, Milano, Italy3 IRCCS Ospedale San Raffaele, Strategic Research Program on CLL, Milano, Italy3 IRCCS Ospedale San Raffaele, Strategic Research Program on CLL, Milano, Italy3 IRCCS Ospedale San Raffaele, Strategic Research Program on CLL, Milano, Italy4 Tel Aviv Sourasky Medical Center, Department of Hematology, Tel Aviv, Israel6 Amsterdam UMC, Department of Hematology, Amsterdam, The Netherlands6 Amsterdam UMC, Department of Hematology, Amsterdam, The Netherlands18 St Antonius Hospital, Department of hematology, Nieuwegein, The Netherlands6 Amsterdam UMC, Department of Hematology, Amsterdam, The Netherlands19 G. Papanicolaou Hospital, Hematology Department-Bone Marrow Transplantation (BMT) Unit, Thessaloniki, Greece8 University Hospital Brno, Department of Internal Medicine-Hematology and Oncology, Brno, Czech Republic10 Medical University of Lublin, Department of Experimental Hematooncology, Lublin, Poland11 University Hospital and Charles University in Prague, 4th Department of Internal Medicine – Hematology, Faculty of Medicine in Hradec Králové, Prague, Czech Republic12 Hospital de la Santa Creu I Sant Pau, Josep Carreras Leukaemia Research Institute, Department of Hematology, Barcelona, Spain13 AO S.Croce e Carle, SC Ematologia, Cuneo, Italy13 AO S.Croce e Carle, SC Ematologia, Cuneo, Italy22 Colentina Clinical Hospital, Hematology, Bucharest, Romania23 National Institute of Virology, Bucharest, Romania3 IRCCS Ospedale San Raffaele, Strategic Research Program on CLL, Milano, Italy1 IRCCS Ospedale San Raffaele, Laboratory of B cell Neoplasia, Milano, Italy1 IRCCS Ospedale San Raffaele, Laboratory of B cell Neoplasia, Milano, Italy7 Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece1 IRCCS Ospedale San Raffaele, Laboratory of B cell Neoplasia, Milano, Italyhttp://journals.lww.com/10.1097/01.HS9.0000972948.48342.7a |
| spellingShingle | Alessandro Campanella Antonella Capasso Caterina Taccetti Silvia Heltai Elisa Albi Yair Herishanu Sabine Haggenburg Thomas Chatzikonstantinou Michael Doubek Magdalena Kättström Krzysztof Giannopoulos Martin Simkovic Carol Moreno Massimo Massaia Horia Bumbea Salem Al Shimmari Pamela Ranghetti Eleonora Perotta Francesca Martini Emanuela Sant’antonio Maria Colia Catalina Combi Shai Levi Arnon Kater Mette Hazenberg Inger Nijhof Quincy Hofsink Christos Demosthenous Jana Kotaskova Joanna Zaleska Filip Vrbacky Alba Mora Davide Bisogno Ignazio Ezio Tripoli Viola Maria Popov Viviana Roman Eloise Scarano Michela Frenquelli Lydia Scarfò Kostas Stamatopoulos Paolo Ghia P1517: HUMORAL AND CELLULAR IMMUNE RESPONSES TO SARS-COV-2 NATURAL INFECTION OR VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL HemaSphere |
| title | P1517: HUMORAL AND CELLULAR IMMUNE RESPONSES TO SARS-COV-2 NATURAL INFECTION OR VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL |
| title_full | P1517: HUMORAL AND CELLULAR IMMUNE RESPONSES TO SARS-COV-2 NATURAL INFECTION OR VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL |
| title_fullStr | P1517: HUMORAL AND CELLULAR IMMUNE RESPONSES TO SARS-COV-2 NATURAL INFECTION OR VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL |
| title_full_unstemmed | P1517: HUMORAL AND CELLULAR IMMUNE RESPONSES TO SARS-COV-2 NATURAL INFECTION OR VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL |
| title_short | P1517: HUMORAL AND CELLULAR IMMUNE RESPONSES TO SARS-COV-2 NATURAL INFECTION OR VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL |
| title_sort | p1517 humoral and cellular immune responses to sars cov 2 natural infection or vaccination in patients with chronic lymphocytic leukemia cll a study by eric the european research initiative on cll |
| url | http://journals.lww.com/10.1097/01.HS9.0000972948.48342.7a |
| work_keys_str_mv | AT alessandrocampanella p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT antonellacapasso p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT caterinataccetti p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT silviaheltai p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT elisaalbi p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT yairherishanu p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT sabinehaggenburg p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT thomaschatzikonstantinou p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT michaeldoubek p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT magdalenakattstrom p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT krzysztofgiannopoulos p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT martinsimkovic p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT carolmoreno p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT massimomassaia p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT horiabumbea p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT salemalshimmari p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT pamelaranghetti p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT eleonoraperotta p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT francescamartini p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT emanuelasantantonio p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT mariacolia p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT catalinacombi p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT shailevi p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT arnonkater p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT mettehazenberg p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT ingernijhof p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT quincyhofsink p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT christosdemosthenous p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT janakotaskova p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT joannazaleska p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT filipvrbacky p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT albamora p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT davidebisogno p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT ignazioeziotripoli p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT violamariapopov p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT vivianaroman p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT eloisescarano p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT michelafrenquelli p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT lydiascarfo p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT kostasstamatopoulos p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll AT paologhia p1517humoralandcellularimmuneresponsestosarscov2naturalinfectionorvaccinationinpatientswithchroniclymphocyticleukemiacllastudybyerictheeuropeanresearchinitiativeoncll |